CVS Health Corp. (NYSE:CVS)

The financial performance from 2020 through 2024 is characterized by improving operational efficiency offset by deteriorating liquidity and volatile profitability. While asset utilization has trended upward consistently, margins and returns on investment have experienced significant fluctuations, including a notable contraction in 2022.

Operational Efficiency

A consistent upward trend is observed in total asset turnover, with both reported and adjusted ratios rising from 1.16 in 2020 to 1.46 by 2024. This indicates a steady improvement in the ability to generate revenue from the asset base over the five-year period.

Liquidity and Solvency

Liquidity has weakened over the analyzed period. The current ratio, both reported and adjusted, has remained below 1.0, declining from 0.91 in 2020 to 0.81 and 0.82 respectively by 2024. Regarding solvency, debt to equity ratios initially declined in 2021 but have since trended upward, with the adjusted ratio reaching 1.04 in 2024. Similarly, financial leverage showed a dip in 2021 before returning to higher levels, ending at 3.35 for reported and 3.17 for adjusted leverage in 2024.

Profitability and Returns

Profitability metrics exhibit high volatility. The adjusted net profit margin plummeted from 2.64% in 2020 to -0.11% in 2022, followed by a recovery to 2.43% in 2023 and a subsequent decline to 1.15% in 2024. This volatility is mirrored in the return on equity (ROE) and return on assets (ROA). Adjusted ROE dropped from 9.20% in 2020 to -0.46% in 2022, recovering to 10.66% in 2023 before falling to 5.32% in 2024. Adjusted ROA followed a similar trajectory, ending the period at 1.68%, significantly lower than the 3.06% recorded in 2020.

In summary, the organization has successfully increased its asset turnover, but this has not translated into stable profitability. The combination of declining liquidity and increasing leverage suggests a tightening financial position, while the volatility in margins and returns indicates susceptibility to significant operational or external shocks, particularly evidenced by the results in 2022 and 2024.

An analysis of the financial performance from 2020 to 2024 reveals a consistent improvement in asset utilization efficiency. The primary driver of this trend is a sustained increase in revenues from customers, which significantly outpaced the growth of the total asset base during the period under review.

Revenue Growth Trend

Revenues from customers exhibited a steady upward trajectory, increasing from 267,908 million US dollars in 2020 to 370,656 million US dollars by 2024. This represents a comprehensive growth pattern characterized by year-over-year gains, providing a larger numerator for the asset turnover calculation.

Asset Base Stability

Total assets remained relatively stable in comparison to revenue growth. While assets shifted from 230,715 million US dollars in 2020 to 253,215 million US dollars in 2024, the growth was modest. A slight contraction was noted in 2022 before the asset base expanded again in 2023 and 2024.

Adjusted Total Asset Turnover Performance

The adjusted total asset turnover ratio demonstrates a clear and consistent upward trend, rising from 1.16 in 2020 to 1.46 in 2024. The most significant acceleration in efficiency occurred between 2021 and 2022, where the ratio increased from 1.25 to 1.41. This indicates that the entity became increasingly effective at generating sales per unit of investment in assets.

Comparison of Reported and Adjusted Metrics

There is a complete convergence between the reported total asset turnover and the adjusted total asset turnover across all five years. The adjusted total assets differ only minimally from the reported total assets, resulting in identical turnover ratios. This suggests that the adjustments applied to the asset base had no material impact on the resulting efficiency metric.

The liquidity profile exhibits a consistent pattern where current liabilities exceed current assets, resulting in a current ratio below 1.0 throughout the five-year period. While there was a moderate recovery in liquidity peaking in 2022, the subsequent years show a tightening of the short-term financial position as liabilities grew at a faster rate than assets.

Asset and Liability Growth Trends

Current assets demonstrated steady growth, increasing from US$ 56,369 million in 2020 to US$ 68,645 million in 2024. During the same interval, current liabilities experienced a more pronounced increase, rising from US$ 62,017 million to US$ 84,609 million. The acceleration of liabilities, particularly between 2022 and 2024, has exerted downward pressure on the company's liquidity ratios.

Adjusted Current Ratio Performance

The adjusted current ratio fluctuated from 0.91 in 2020 to a peak of 0.95 in 2022, before declining to 0.82 by December 31, 2024. This downward trend since 2022 indicates that for every dollar of short-term obligation, the company holds approximately 82 cents in adjusted current assets, marking the lowest liquidity level in the observed period.

Analysis of Reported versus Adjusted Metrics

Adjusted current assets are consistently higher than reported current assets across all years. This adjustment results in an adjusted current ratio that is marginally superior to the reported current ratio. For instance, by 2024, the adjusted current ratio of 0.82 provided a slight improvement over the reported ratio of 0.81, although the impact of the adjustment is minimal and does not alter the primary downward trend of the liquidity position.

The financial data indicates a period of fluctuating leverage between 2020 and 2024, characterized by an initial reduction in debt followed by a steady increase. While shareholders' equity remained relatively stable throughout the period, the overall debt profile experienced a V-shaped trajectory, impacting both reported and adjusted solvency ratios.

Debt and Equity Trends

Total debt decreased from 64,647 million USD in 2020 to a low of 52,254 million USD in 2022, before climbing back to 66,270 million USD by the end of 2024. Parallel to this, adjusted total debt followed a similar pattern, declining from 85,042 million USD in 2020 to 70,732 million USD in 2022, and subsequently rising to 82,920 million USD in 2024. Total shareholders' equity and adjusted shareholders' equity exhibited less volatility, fluctuating within a range of approximately 69,000 million to 82,000 million USD over the five-year period.

Analysis of Adjusted Debt to Equity Ratio

The adjusted debt to equity ratio experienced a significant contraction from 1.11 in 2020 to 0.93 in 2021. Following this decline, a gradual upward trend is observed, with the ratio rising to 0.94 in 2022, 0.98 in 2023, and reaching 1.04 by December 31, 2024. This indicates a steady increase in the company's reliance on debt relative to adjusted equity over the last three years of the analyzed period.

Reported versus Adjusted Metrics

A consistent gap exists between reported and adjusted figures. The adjusted debt to equity ratio remains higher than the reported ratio in every measured year, suggesting that the adjustments incorporate additional liabilities or modified equity valuations that present a more conservative view of the company's leverage. For example, by December 31, 2024, the reported debt to equity ratio stood at 0.88, while the adjusted ratio was higher at 1.04.

The financial data indicates a U-shaped trajectory in leverage metrics between 2020 and 2024. A period of deleveraging occurred from 2020 to 2022, characterized by a reduction in both total and adjusted debt, followed by a consistent upward trend in borrowing and total capital from 2023 through 2024.

Adjusted Debt to Capital Ratio Trends

The adjusted debt to capital ratio decreased from 0.53 in 2020 to a low of 0.48 in 2021 and 2022. Since 2022, the ratio has experienced a gradual increase, rising to 0.49 in 2023 and reaching 0.51 by December 31, 2024. This suggests a moderate increase in the reliance on debt relative to total capital in the most recent two fiscal years.

Debt and Capital Volume Analysis

Adjusted total debt declined from US$ 85,042 million in 2020 to a minimum of US$ 70,732 million in 2022. However, this trend reversed sharply, with debt increasing to US$ 79,385 million in 2023 and further to US$ 82,920 million in 2024. Similarly, adjusted total capital fell from US$ 161,895 million in 2020 to US$ 146,129 million in 2022, before recovering to US$ 162,863 million by the end of 2024.

Comparison of Reported and Adjusted Metrics

A consistent variance exists between reported and adjusted figures. Adjusted total debt and adjusted total capital are significantly higher than their reported counterparts across all five years. The adjusted debt to capital ratio remains consistently higher than the reported ratio, which ranged from 0.42 to 0.48 over the same period. This gap indicates that the adjustments account for a substantial amount of additional liabilities and capital not captured in the standard reported figures.

An analysis of the financial leverage from 2020 to 2024 reveals a period of relative stability characterized by a slight U-shaped trend. After an initial decrease in leverage in 2021, there has been a steady incremental increase through the end of 2024.

Asset and Equity Growth

Total assets grew from US$ 230,715 million in 2020 to US$ 253,215 million in 2024, reflecting a general expansion of the balance sheet despite a minor contraction in 2022. During the same period, total shareholders’ equity increased from US$ 69,389 million to US$ 75,560 million. The fact that asset growth outpaced equity growth contributed to the upward pressure on leverage ratios observed from 2022 onward.

Comparison of Reported and Adjusted Leverage

A consistent divergence is observed between reported and adjusted financial leverage. The reported leverage fluctuated between a low of 3.10 in 2021 and a high of 3.35 in 2024. In contrast, the adjusted leverage remained systematically lower, ranging between 2.85 and 3.17. This difference is driven by the adjusted shareholders' equity, which was consistently higher than the reported equity throughout the five-year period.

Adjusted Financial Leverage Trends

The adjusted financial leverage ratio reached its minimum in 2021 at 2.85. Following this trough, the ratio rose incrementally to 3.03 in 2022, 3.08 in 2023, and 3.17 in 2024. This upward trajectory indicates a gradual increase in the utilization of leverage relative to adjusted equity over the most recent four-year cycle.

Financial performance analysis reveals a marked divergence between consistent revenue expansion and volatile profitability margins over the five-year period ending December 31, 2024.

Revenue Trajectory

Revenues from customers exhibited an uninterrupted upward trend, growing from 267,908 million US dollars in 2020 to 370,656 million US dollars in 2024. This steady increase indicates a consistent expansion of the top-line scale.

Adjusted Net Profit Margin Trends

The adjusted net profit margin experienced significant instability. After starting at 2.64% in 2020 and 2.41% in 2021, the margin entered a period of extreme volatility, dropping to a negative 0.11% in 2022. While a recovery occurred in 2023, bringing the margin back to 2.43%, a subsequent decline was observed in 2024, with the margin falling to 1.15%.

Adjusted versus Reported Profitability

Variations between reported and adjusted metrics highlight anomalous periods. In 2022, the reported net profit margin remained positive at 1.29% despite the adjusted net profit margin falling into negative territory. Conversely, in 2023, the adjusted net profit margin of 2.43% surpassed the reported margin of 2.34%. By 2024, both metrics declined and converged, ending at 1.24% for reported and 1.15% for adjusted margins.

Net Income Fluctuations

Adjusted net income mirrored the margin volatility, shifting from 7,071 million US dollars in 2020 to a loss of 346 million US dollars in 2022. A peak was reached in 2023 with adjusted net income of 8,669 million US dollars, followed by a sharp decrease to 4,255 million US dollars in 2024.

Overall, the data indicates that the organization has successfully scaled its revenue base, but this growth has not translated into stable net profitability, as evidenced by the cyclical and sharp fluctuations in adjusted net profit margins.

The Return on Equity (ROE) for CVS Health exhibits significant volatility over the five-year period ending December 31, 2024. While the equity base has remained relatively stable, substantial fluctuations in net income have resulted in an inconsistent return profile for shareholders.

Adjusted Return on Equity Trends

Adjusted ROE followed a volatile trajectory, starting at 9.20% in 2020 and declining slightly to 8.54% in 2021. A sharp contraction occurred in 2022, with the ratio falling to -0.46%. This was followed by a strong recovery in 2023, reaching a peak of 10.66%, before decreasing again to 5.32% in 2024.

Comparative Analysis of Reported and Adjusted ROE

Reported ROE consistently outperformed Adjusted ROE in most years, with the most notable divergence occurring in 2022. During that year, Reported ROE remained positive at 5.84%, whereas Adjusted ROE turned negative, suggesting that non-adjusted components significantly impacted the bottom line. By 2023, the two metrics converged more closely, with Reported ROE at 10.91% and Adjusted ROE at 10.66%.

Equity Base Stability

Adjusted total shareholders' equity demonstrated relative stability, moving from 76,853 million US dollars in 2020 to 79,943 million US dollars in 2024. The lack of dramatic shifts in the equity denominator indicates that the volatility observed in the ROE percentages is primarily driven by swings in net income rather than aggressive recapitalization or significant changes in the capital structure.

Correlation with Adjusted Net Income

The fluctuations in Adjusted ROE are directly correlated with the volatility of Adjusted Net Income. The negative ROE in 2022 corresponds to an adjusted net loss of 346 million US dollars. Conversely, the peak ROE in 2023 aligns with the highest adjusted net income of 8,669 million US dollars recorded in the analyzed period.

The analysis of asset efficiency over the five-year period from 2020 to 2024 reveals significant volatility in the Adjusted Return on Assets (ROA), characterized by sharp fluctuations in adjusted net income despite a steady increase in the asset base.

Adjusted ROA Performance and Volatility

The Adjusted ROA remained relatively stable between 2020 and 2021, hovering around 3.0%. A severe contraction occurred in 2022, with the ratio dropping to -0.15%, driven by an adjusted net loss of 346 million US$. This was followed by a sharp recovery in 2023, where the Adjusted ROA reached a period peak of 3.47%. However, a subsequent decline is observed in 2024, with the ratio falling to 1.68%.

Divergence Between Reported and Adjusted Metrics

A notable divergence between reported and adjusted figures is evident in 2022. While the reported ROA remained positive at 1.82%, the adjusted ROA turned negative, indicating that non-adjusted items provided a cushion that masked an underlying operational decline in adjusted profitability. Conversely, in 2023, the adjusted ROA of 3.47% outperformed the reported ROA of 3.34%, suggesting that adjusted earnings were stronger than the reported figures.

Asset Base Expansion and Efficiency

Total assets demonstrated a consistent upward trend, growing from 230,715 million US$ in 2020 to 253,215 million US$ in 2024. The lack of a corresponding linear increase in Adjusted ROA suggests that the growth in the asset base has not translated into sustained improvements in capital efficiency. The decline in ROA in 2024, occurring alongside the highest recorded asset levels, indicates a decrease in the efficiency of asset utilization.